|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui Z, Chen Y, Xiao Z, Hu M, Lin Y, Chen Y
and Zheng Y: Long noncoding RNAs as auxiliary biomarkers for
gastric cancer screening: A pooled analysis of individual studies.
Oncotarget. 7:25791–800. 2016.PubMed/NCBI
|
|
3
|
ENCODE Project Consortium, Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kapranov P, Willingham AT and Gingeras TR:
Genome-wide transcription and the implications for genomic
organization. Nat Rev Genet. 8:413–423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sana J, Faltejskova P, Svoboda M and Slaby
O: Novel classes of non-coding RNAs and cancer. J Transl Med.
10:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blythe AJ, Fox AH and Bond CS: The ins and
outs of lncRNA structure: How, why and what comes next. Biochim
Biophys Acta. 1859:46–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth
by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brown CJ, Ballabio A, Rupert JL,
Lafreniere RG, Grompe M, Tonlorenzi R and Willard HF: A gene from
the region of the human X inactivation centre is expressed
exclusively from the inactive X chromosome. Nature. 349:38–44.
1991. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song H, He P, Shao T, Li Y, Li J and Zhang
Y: Long non-coding RNA XIST functions as an oncogene in human
colorectal cancer by targeting miR-132-3p. J BUON. 22:696–703.
2017.PubMed/NCBI
|
|
13
|
Hu Y, Deng C, Zhang H, Zhang J, Peng B and
Hu C: Long non-coding RNA XIST promotes cell growth and metastasis
through regulating miR-139-5p mediated Wnt/β-catenin signaling
pathway in bladder cancer. Oncotarget. 8:94554–94568. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma L, Zhou Y, Luo X, Gao H, Deng X and
Jiang Y: Long non-coding RNA XIST promotes cell growth and invasion
through regulating miR-497/MACC1 axis in gastric cancer.
Oncotarget. 8:4125–4135. 2017.PubMed/NCBI
|
|
15
|
Song P, Ye LF, Zhang C, Peng T and Zhou
XH: Long non-coding RNA XIST exerts oncogenic functions in human
nasopharyngeal carcinoma by targeting miR-34a-5p. Gene. 592:8–14.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang YS, Chang CC, Lee SS, Jou YS and
Shih HM: Xist reduction in breast cancer upregulates AKT
phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Oncotarget. 7:43256–43266. 2016.PubMed/NCBI
|
|
18
|
Du Y, Weng XD, Wang L, Liu XH, Zhu HC, Guo
J, Ning JZ and Xiao CC: LncRNA XIST acts as a tumor suppressor in
prostate cancer through sponging miR-23a to modulate RKIP
expression. Oncotarget. 8:94358–94370. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kobayashi R, Miyagawa R, Yamashita H,
Morikawa T, Okuma K, Fukayama M, Ohtomo K and Nakagawa K: Increased
expression of long non-coding RNA XIST predicts favorable prognosis
of cervical squamous cell carcinoma subsequent to definitive
chemoradiation therapy. Oncol Lett. 12:3066–3074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu S, Chang J, Li Y, Wang W, Guo M, Zou
EC, Wang Y and Yang Y: Long non-coding RNA XIST as a potential
prognostic biomarker in human cancers: A meta-analysis. Oncotarget.
9:13911–13919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao H, Wang K, Feng Y, Zhang J, Pan L,
Zhan Y, Sheng H and Luo G. Prognostic role of long non-coding RNA
XIST expression in patients with solid tumors: A meta-analysis.
Cancer Cell Int. 18:342018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Ming X, Jing W, Luo P, Li N, Zhu M,
Yu M, Liang C and Tu J: Long non-coding RNA XIST predicts worse
prognosis in digestive system tumors: A systemic review and
meta-analysis. Biosci Rep. 38:BSR201801692018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun K, Jia Z, Duan R, Yan Z, Jin Z, Yan L,
Li Q and Yang J: Long non-coding RNA XIST regulates miR-106b-5p/P21
axis to suppress tumor progression in renal cell carcinoma. Biochem
Biophys Res Commun. 510:416–420. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang R and Xia T: Long non-coding RNA
XIST regulates PDCD4 expression by interacting with miR-21-5p and
inhibits osteosarcoma cell growth and metastasis. Int J Oncol.
51:1460–1470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: A
proposal for reporting. Meta-analysis of Observational Studies in
Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Enneking WF: A system of staging
musculoskeletal neoplasms. Clin Orthop Relat Res. 9–24.
1986.PubMed/NCBI
|
|
27
|
Zhang Q, Wang J, Deng F, Yan Z, Xia Y,
Wang Z, Ye J, Deng Y, Zhang Z, Qiao M, et al: TqPCR: A touchdown
qPCR assay with significantly improved detection sensitivity and
amplification efficiency of SYBR green qPCR. PLoS One.
10:e01326662015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bowden J, Tierney JF, Copas AJ and Burdett
S: Quantifying, displaying and accounting for heterogeneity in the
meta-analysis of RCTs using standard and generalised Q statistics.
BMC Med Res Methodol. 11:412011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle–Ottawa Scale (NOS)
for assessing the quality of nonrandomized studies in
meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspJune
15–2019
|
|
32
|
Tantai J, Hu D, Yang Y and Geng J:
Combined identification of long non-coding RNA XIST and HIF1A-AS1
in serum as an effective screening for non-small cell lung cancer.
Int J Clin Exp Pathol. 8:7887–7895. 2015.PubMed/NCBI
|
|
33
|
Fang J, Sun CC and Gong C: Long noncoding
RNA XIST acts as an oncogene in non-small cell lung cancer by
epigenetically repressing KLF2 expression. Biochem Biophys Res
Commun. 478:811–817. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li GL, Wu YX, Li YM and Li J: High
expression of long non-coding RNA XIST in osteosarcoma is
associated with cell proliferation and poor prognosis. Eur Rev Med
Pharmacol Sci. 21:2829–2834. 2017.PubMed/NCBI
|
|
36
|
Chen DL, Chen LZ, Lu YX, Zhang DS, Zeng
ZL, Pan ZZ, Huang P, Wang FH, Li YH, Ju HQ and Xu RH: Long
noncoding RNA XIST expedites metastasis and modulates
epithelial-mesenchymal transition in colorectal cancer. Cell Death
Dis. 8:e30112017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei W, Liu Y, Lu Y, Yang B and Tang L:
LncRNA XIST promotes pancreatic cancer proliferation through
miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng
G and Liao Y: LncRNA-XIST interacts with miR-29c to modulate the
chemoresistance of glioma cell to TMZ through DNA mismatch repair
pathway. Biosci Rep. 37:BSR201706962017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Z, Yuan J, Li L, Yang Y, Xu X and
Wang Y: Long non-coding RNA XIST exerts oncogenic functions in
human glioma by targeting miR-137. Am J Transl Res. 9:1845–1855.
2017.PubMed/NCBI
|
|
40
|
Mo Y, Lu Y, Wang P, Huang S, He L, Li D,
Li F, Huang J, Lin X, Li X, et al: Long non-coding RNA XIST
promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in
hepatocellular carcinoma. Tumour Biol. 39:10104283176909992017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun G, Wang C and Zhang H: Long non-coding
RNA XIST promotes cervical cancer cell epithelial-mesenchymal
transition through the Wnt/β-catenin pathway. Int J Clin Exp
Pathol. 10:2333–2339. 2017.
|
|
42
|
Xiong Y, Wang L, Li Y, Chen M, He W and Qi
L: The long non-coding RNA XIST interacted with MiR-124 to modulate
bladder cancer growth, invasion and migration by targeting androgen
receptor (AR). Cell Physiol Biochem. 43:405–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun W, Zu Y, Fu X and Deng Y: Knockdown of
lncRNA-XIST enhances the chemosensitivity of NSCLC cells via
suppression of autophagy. Oncol Rep. 38:3347–3354. 2017.PubMed/NCBI
|
|
44
|
Wu X, Dinglin X, Wang X, Luo W, Shen Q, Li
Y, Gu L, Zhou Q, Zhu H, Li Y, et al: Long noncoding RNA XIST
promotes malignancies of esophageal squamous cell carcinoma via
regulation of miR-101/EZH2. Oncotarget. 8:76015–76028.
2017.PubMed/NCBI
|
|
45
|
Kong Q, Zhang S, Liang C, Zhang Y, Kong Q,
Chen S, Qin J and Jin Y: LncRNA XIST functions as a molecular
sponge of miR-194-5p to regulate MAPK1 expression in hepatocellular
carcinoma cell. J Cell Biochem. 119:4458–4468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yi SZ, Zhang W, Zhou QY and Cheng GR:
lncRNA XIST promotes aggressive tumor phenotype and is associated
with poor prognosis in esophageal squamous cell carcinoma. Int J
Clin Exp Med. 11:8317–8323. 2018.
|
|
47
|
Liang S, Gong X, Zhang G, Huang G, Lu Y
and Li Y: The lncRNA XIST interacts with miR-140/miR-124/iASPP axis
to promote pancreatic carcinoma growth. Oncotarget.
8:113701–113718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun N, Zhang G and Liu Y: Long non-coding
RNA XIST sponges miR-34a to promotes colon cancer progression via
Wnt/β-catenin signaling pathway. Gene. 665:141–148. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu H, Deng H, Zhao Y, Li C and Liang Y:
LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor
growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin
Cancer Res. 37:2792018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hu C, Liu S, Han M, Wang Y and Xu C:
Knockdown of lncRNA XIST inhibits retinoblastoma progression by
modulating the miR-124/STAT3 axis. Biomed Pharmacother.
107:547–554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhu H, Zheng T, Yu J, Zhou L and Wang L:
LncRNA XIST accelerates cervical cancer progression via
upregulating Fus through competitively binding with miR-200a.
Biomed Pharmacother. 105:789–797. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cui X, Jing X, Long C, Tian J and Zhu J:
Long noncoding RNA MEG3, a potential novel biomarker to predict the
clinical outcome of cancer patients: A meta-analysis. Oncotarget.
8:19049–19056. 2017.PubMed/NCBI
|
|
56
|
Fan YH, Fang H, Ji CX, Xie H, Xiao B and
Zhu XG: Long noncoding RNA CCAT2 can predict metastasis and poor
prognosis: A meta-analysis. Clin Chim Acta. 466:120–126. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang S, Chen S, Yang G, Gu F, Li M, Zhong
B, Hu J, Hoffman A and Chen M: Long noncoding RNA HOTAIR as an
independent prognostic marker in cancer: A meta-analysis. PLoS One.
9:e1055382014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhu J, Kong F, Xing L, Jin Z and Li Z:
Prognostic and clinicopathological value of long noncoding RNA XIST
in cancer. Clin Chim Acta. 479:43–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
